injection of NaCl 0.9% — Competitive Intelligence Brief

injection of NaCl 0.9% (injection of NaCl 0.9%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte solution. Area: Fluid and electrolyte management.

phase 3 Electrolyte solution Fluid and electrolyte management Small molecule

Target snapshot

injection of NaCl 0.9% (injection of NaCl 0.9%) — Assistance Publique - Hôpitaux de Paris. This drug works by replenishing fluids and electrolytes in the body.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
injection of NaCl 0.9% TARGET	injection of NaCl 0.9%	Assistance Publique - Hôpitaux de Paris	phase 3	Electrolyte solution
Plegisol In Plastic Container	Sodium Chloride	Baxter	marketed	Electrolyte solution	Not specified	1965-01-01
Plegisol In Plastic Container	Sodium Chloride	Baxter	marketed	Electrolyte solution	Not specified	1965-01-01
Sodium Chloride [3%]	Sodium Chloride [3%]	Fundacion Clinica Valle del Lili	marketed	Electrolyte solution / Osmotic agent
NaCl 7.5%	NaCl 7.5%	Aristotle University Of Thessaloniki	marketed	Osmotic agent / Electrolyte solution
Normal saline application	Normal saline application	Keimyung University Dongsan Medical Center	marketed	Electrolyte solution / Crystalloid fluid
Saline solution ("B")	Saline solution ("B")	Hospital Universitari de Bellvitge	marketed	Electrolyte solution / Fluid replacement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte solution class)

1. Baxter · 2 drugs in this class
2. Assistance Publique - Hôpitaux de Paris · 1 drug in this class
3. Pfizer Inc. · 1 drug in this class